{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T00:54:46Z","timestamp":1794272086468,"version":"4.9.0"},"reference-count":60,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T00:00:00Z","timestamp":1700784000000},"content-version":"unspecified","delay-in-days":23,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Italian Ministry of Health","doi-asserted-by":"crossref","award":["GR-2018-12366771"],"award-info":[{"award-number":["GR-2018-12366771"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003196","name":"Italian Ministry of Health","doi-asserted-by":"crossref","award":["RRC 2023"],"award-info":[{"award-number":["RRC 2023"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Neurol Open"],"accepted":{"date-parts":[[2023,10,10]]},"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Heterozygous mutations in the\n                      <jats:italic>GBA<\/jats:italic>\n                      gene, encoding the lysosomal enzyme \u03b2-glucocerebrosidase (GCase), are the most frequent genetic risk factor for Parkinson\u2019s disease (PD).\n                      <jats:italic>GBA<\/jats:italic>\n                      -related PD (GBA-PD) patients have higher risk of dementia and reduced survival than non-carriers. Preclinical studies and one open-label trial in humans demonstrated that the chaperone ambroxol (ABX) increases GCase levels and modulates \u03b1-synuclein levels in the blood and cerebrospinal fluid (CSF).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>In this multicentre, double-blind, placebo-controlled, phase II clinical trial, we randomise patients with GBA-PD in a 1:1 ratio to either oral ABX 1.2\u2009g\/day or placebo. The duration of treatment is 52 weeks. Each participant is assessed at baseline and weeks 12, 26, 38, 52 and 78. Changes in the Montreal Cognitive Assessment score and the frequency of mild cognitive impairment and dementia between baseline and weeks 52 are the primary outcome measures. Secondary outcome measures include changes in validated scales\/questionnaires assessing motor and non-motor symptoms. Neuroimaging features and CSF neurodegeneration markers are used as surrogate markers of disease progression. GCase activity, ABX and \u03b1-synuclein levels are also analysed in blood and CSF. A repeated-measures analysis of variance will be used for elaborating results. The primary analysis will be by intention to treat.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>The study and protocols have been approved by the ethics committee of centres. The study is conducted according to good clinical practice and the Declaration of Helsinki. The trial findings will be published in peer-reviewed journals and presented at conferences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration numbers<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT05287503\">NCT05287503<\/jats:ext-link>\n                      , EudraCT 2021-004565-13.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjno-2023-000535","type":"journal-article","created":{"date-parts":[[2023,11,25]],"date-time":"2023-11-25T00:50:22Z","timestamp":1700873422000},"page":"e000535","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":48,"title":["Ambroxol as a disease-modifying treatment to reduce the risk of cognitive impairment in\n                    <i>GBA<\/i>\n                    -associated Parkinson\u2019s disease: a multicentre, randomised, double-blind, placebo-controlled, phase II trial. The AMBITIOUS study protocol"],"prefix":"10.1136","volume":"5","clinical-trial-number":[{"clinical-trial-number":"nct05287503","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02914366","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02941822","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02941822","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct05287503","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Fabiana","family":"Colucci","sequence":"first","affiliation":[{"name":"Department of Clinical Neurosciences, Parkinson and Movement Disorders Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy"},{"name":"Department of Neuroscience and Rehabilitation, University of Ferrara, Ferrara, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micol","family":"Avenali","sequence":"additional","affiliation":[{"name":"Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy"},{"name":"IRCCS Mondino Foundation, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosita","family":"De Micco","sequence":"additional","affiliation":[{"name":"Department of Advanced Medical and Surgical Sciences, University of Campania \"Luigi Vanvitelli\", Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Fusar Poli","sequence":"additional","affiliation":[{"name":"Neuropsychology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Cerri","sequence":"additional","affiliation":[{"name":"IRCCS Mondino Foundation, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Stanziano","sequence":"additional","affiliation":[{"name":"Neuroradiology Unit, Foundation IRCCS Carlo Besta Neurological Institute, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Bacila","sequence":"additional","affiliation":[{"name":"IRCCS Mondino Foundation, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giada","family":"Cuconato","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, University of Pavia, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Franco","sequence":"additional","affiliation":[{"name":"IRCCS Mondino Foundation, Pavia, Italy"},{"name":"Division of Clinical and Experimental Pharmacology, Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Franciotta","sequence":"additional","affiliation":[{"name":"IRCCS Mondino Foundation, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Ghezzi","sequence":"additional","affiliation":[{"name":"IRCCS Mondino Foundation, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Gastaldi","sequence":"additional","affiliation":[{"name":"IRCCS Mondino Foundation, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Emanuele","family":"Elia","sequence":"additional","affiliation":[{"name":"Department of Clinical Neurosciences, Parkinson and Movement Disorders Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Romito","sequence":"additional","affiliation":[{"name":"Department of Clinical Neurosciences, Parkinson and Movement Disorders Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grazia","family":"Devigili","sequence":"additional","affiliation":[{"name":"Department of Clinical Neurosciences, Parkinson and Movement Disorders Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Leta","sequence":"additional","affiliation":[{"name":"Department of Clinical Neurosciences, Parkinson and Movement Disorders Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy"},{"name":"Parkinson's Centre of Excellence, King's College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Garavaglia","sequence":"additional","affiliation":[{"name":"Unit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nico","family":"Golfr\u00e8 Andreasi","sequence":"additional","affiliation":[{"name":"Department of Clinical Neurosciences, Parkinson and Movement Disorders Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Cazzaniga","sequence":"additional","affiliation":[{"name":"Unit of Neurology 5 and Neuropathology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Reale","sequence":"additional","affiliation":[{"name":"Unit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Galandra","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, University of Pavia, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Germani","sequence":"additional","affiliation":[{"name":"IRCCS Mondino Foundation, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierfrancesco","family":"Mitrotti","sequence":"additional","affiliation":[{"name":"Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo","family":"Ongari","sequence":"additional","affiliation":[{"name":"IRCCS Mondino Foundation, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Palmieri","sequence":"additional","affiliation":[{"name":"IRCCS Mondino Foundation, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Picascia","sequence":"additional","affiliation":[{"name":"IRCCS Mondino Foundation, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Pichiecchio","sequence":"additional","affiliation":[{"name":"Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy"},{"name":"IRCCS Mondino Foundation, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Verri","sequence":"additional","affiliation":[{"name":"Neuroradiology Unit, Foundation IRCCS Carlo Besta Neurological Institute, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Esposito","sequence":"additional","affiliation":[{"name":"Department of Advanced Medical and Surgical Sciences, University of Campania \"Luigi Vanvitelli\", Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Cirillo","sequence":"additional","affiliation":[{"name":"Department of Advanced Medical and Surgical Sciences, University of Campania \"Luigi Vanvitelli\", Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Di Nardo","sequence":"additional","affiliation":[{"name":"Department of Advanced Medical and Surgical Sciences, University of Campania \"Luigi Vanvitelli\", Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Aloisio","sequence":"additional","affiliation":[{"name":"Department of Advanced Medical and Surgical Sciences, University of Campania \"Luigi Vanvitelli\", Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Siciliano","sequence":"additional","affiliation":[{"name":"Department of Advanced Medical and Surgical Sciences, University of Campania \"Luigi Vanvitelli\", Naples, Italy"},{"name":"Department of Psychology, University of Campania Luigi Vanvitelli, Caserta, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Prioni","sequence":"additional","affiliation":[{"name":"Neuropsychology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Amami","sequence":"additional","affiliation":[{"name":"Neuropsychology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Piacentini","sequence":"additional","affiliation":[{"name":"Neuropsychology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Bruzzone","sequence":"additional","affiliation":[{"name":"Neuroradiology Unit, Foundation IRCCS Carlo Besta Neurological Institute, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Grisoli","sequence":"additional","affiliation":[{"name":"Neuroradiology Unit, Foundation IRCCS Carlo Besta Neurological Institute, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Moda","sequence":"additional","affiliation":[{"name":"Unit of Neurology 5 and Neuropathology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Eleopra","sequence":"additional","affiliation":[{"name":"Department of Clinical Neurosciences, Parkinson and Movement Disorders Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Tessitore","sequence":"additional","affiliation":[{"name":"Department of Advanced Medical and Surgical Sciences, University of Campania \"Luigi Vanvitelli\", Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enza Maria","family":"Valente","sequence":"additional","affiliation":[{"name":"IRCCS Mondino Foundation, Pavia, Italy"},{"name":"Department of Molecular Medicine, University of Pavia, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1990-1939","authenticated-orcid":false,"given":"Roberto","family":"Cilia","sequence":"additional","affiliation":[{"name":"Department of Clinical Neurosciences, Parkinson and Movement Disorders Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,11,24]]},"reference":[{"key":"2025072812075220000_5.2.e000535.1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30295-3"},{"key":"2025072812075220000_5.2.e000535.2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2013-305277"},{"key":"2025072812075220000_5.2.e000535.3","doi-asserted-by":"crossref","DOI":"10.1007\/s11910-018-0860-4","article-title":"GBA-associated Parkinson's disease and other synucleinopathies","volume":"18","author":"Gan-Or","year":"2018","journal-title":"Curr Neurol Neurosci Rep"},{"key":"2025072812075220000_5.2.e000535.4","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddq454"},{"key":"2025072812075220000_5.2.e000535.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0901281"},{"key":"2025072812075220000_5.2.e000535.6","first-page":"3136415","article-title":"A meta-analysis of GBA-related clinical symptoms in Parkinson's disease","volume":"2018","author":"Zhang","year":"2018","journal-title":"Parkinsons Dis"},{"key":"2025072812075220000_5.2.e000535.7","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aws318"},{"key":"2025072812075220000_5.2.e000535.8","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awz350"},{"key":"2025072812075220000_5.2.e000535.9","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(12)70190-4"},{"key":"2025072812075220000_5.2.e000535.10","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24777"},{"key":"2025072812075220000_5.2.e000535.11","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.b.32549"},{"key":"2025072812075220000_5.2.e000535.12","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.5845","article-title":"Association of dual Lrrk2 G2019S and GBA variations with Parkinson disease progression","volume":"4","author":"Ortega","year":"2021","journal-title":"JAMA Netw Open"},{"key":"2025072812075220000_5.2.e000535.13","doi-asserted-by":"crossref","unstructured":"Ren J , Zhan X , Zhou H , et al . Comparing the effects of GBA variants and onset age on clinical features and progression in Parkinson\u2019s disease. CNS Neurosci Ther August 10, 2023. doi:10.1111\/cns.14387","DOI":"10.1111\/cns.14387"},{"key":"2025072812075220000_5.2.e000535.14","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318245f476"},{"key":"2025072812075220000_5.2.e000535.15","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/ene.15230","article-title":"Prevalence and genotype-phenotype correlations of GBA-related Parkinson disease in a large Chinese cohort","volume":"29","author":"Ren","year":"2022","journal-title":"Eur J Neurol"},{"key":"2025072812075220000_5.2.e000535.16","doi-asserted-by":"publisher","DOI":"10.1001\/jama.298.11.1281"},{"key":"2025072812075220000_5.2.e000535.17","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000304039.11891.29"},{"key":"2025072812075220000_5.2.e000535.18","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awp044"},{"key":"2025072812075220000_5.2.e000535.19","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21892"},{"key":"2025072812075220000_5.2.e000535.20","doi-asserted-by":"publisher","DOI":"10.1126\/science.256.5058.794"},{"key":"2025072812075220000_5.2.e000535.21","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-444-59565-2.00040-X"},{"key":"2025072812075220000_5.2.e000535.22","doi-asserted-by":"publisher","DOI":"10.1002\/humu.20676"},{"key":"2025072812075220000_5.2.e000535.23","doi-asserted-by":"publisher","DOI":"10.1002\/mds.28225"},{"key":"2025072812075220000_5.2.e000535.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2005.07.005"},{"key":"2025072812075220000_5.2.e000535.25","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001315"},{"key":"2025072812075220000_5.2.e000535.26","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2017-317348"},{"key":"2025072812075220000_5.2.e000535.27","doi-asserted-by":"publisher","DOI":"10.1002\/ana.26636"},{"key":"2025072812075220000_5.2.e000535.28","doi-asserted-by":"crossref","first-page":"e388","DOI":"10.1212\/WNL.0000000000201418","article-title":"Association of CSF Glucocerebrosidase activity with the risk of incident dementia in patients with Parkinson disease","volume":"100","author":"Oftedal","year":"2023","journal-title":"Neurology"},{"key":"2025072812075220000_5.2.e000535.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2014.12.001"},{"key":"2025072812075220000_5.2.e000535.30","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awv179"},{"key":"2025072812075220000_5.2.e000535.31","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1108197108"},{"key":"2025072812075220000_5.2.e000535.32","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1220464110"},{"key":"2025072812075220000_5.2.e000535.33","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27414"},{"key":"2025072812075220000_5.2.e000535.34","doi-asserted-by":"crossref","DOI":"10.1186\/s40035-020-00226-x","article-title":"Cross-talks among GBA mutations, glucocerebrosidase, and \u0391-synuclein in GBA-associated Parkinson\u2019s disease and their targeted therapeutic approaches: a comprehensive review","volume":"10","author":"Behl","year":"2021","journal-title":"Transl Neurodegener"},{"key":"2025072812075220000_5.2.e000535.35","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27583"},{"key":"2025072812075220000_5.2.e000535.36","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/cpdd.865","article-title":"Pharmacokinetics, pharmacodynamics, safety, and tolerability of oral venglustat in healthy volunteers","volume":"10","author":"Peterschmitt","year":"2021","journal-title":"Clin Pharmacol Drug Dev"},{"key":"2025072812075220000_5.2.e000535.37","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.4.8.1119"},{"key":"2025072812075220000_5.2.e000535.38","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awu020"},{"key":"2025072812075220000_5.2.e000535.39","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.012393"},{"key":"2025072812075220000_5.2.e000535.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.braindev.2012.05.008"},{"key":"2025072812075220000_5.2.e000535.41","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.stemcr.2017.01.011","article-title":"A human neural crest stem cell-derived dopaminergic neuronal model recapitulates biochemical abnormalities in Gba1 mutation carriers","volume":"8","author":"Yang","year":"2017","journal-title":"Stem Cell Reports"},{"key":"2025072812075220000_5.2.e000535.42","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24790"},{"key":"2025072812075220000_5.2.e000535.43","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2012.09.006"},{"key":"2025072812075220000_5.2.e000535.44","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/acn3.292","article-title":"Ambroxol chaperone therapy for neuronopathic Gaucher disease: a pilot study","volume":"3","author":"Narita","year":"2016","journal-title":"Ann Clin Transl Neurol"},{"key":"2025072812075220000_5.2.e000535.45","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12883-019-1252-3","article-title":"Ambroxol as a novel disease-modifying treatment for Parkinson's disease dementia: protocol for a single-centre, randomized, double-blind, placebo-controlled trial","volume":"19","author":"Silveira","year":"2019","journal-title":"BMC Neurol"},{"key":"2025072812075220000_5.2.e000535.46","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/jamaneurol.2019.4611","article-title":"Ambroxol for the treatment of patients with Parkinson disease with and without glucocerebrosidase gene mutations: a nonrandomized, noncontrolled trial","volume":"77","author":"Mullin","year":"2020","journal-title":"JAMA Neurol"},{"key":"2025072812075220000_5.2.e000535.47","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1212\/WNL.0000000000001037","article-title":"Resting-state fMRI sheds light on neural substrates of cognitive decline in Parkinson disease","volume":"83","author":"Shinotoh","year":"2014","journal-title":"Neurology"},{"key":"2025072812075220000_5.2.e000535.48","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26424"},{"key":"2025072812075220000_5.2.e000535.49","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21507"},{"key":"2025072812075220000_5.2.e000535.50","doi-asserted-by":"publisher","DOI":"10.1002\/mds.24059"},{"key":"2025072812075220000_5.2.e000535.51","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181fc29c9"},{"key":"2025072812075220000_5.2.e000535.52","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181c34b47"},{"key":"2025072812075220000_5.2.e000535.53","doi-asserted-by":"publisher","DOI":"10.1002\/mds.24893"},{"key":"2025072812075220000_5.2.e000535.54","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1002\/mds.28496","article-title":"Profiling the biochemical signature of GBA-related Parkinson's disease in peripheral blood mononuclear cells","volume":"36","author":"Avenali","year":"2021","journal-title":"Mov Disord"},{"key":"2025072812075220000_5.2.e000535.55","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.parkreldis.2015.12.002","article-title":"Leukocyte glucocerebrosidase and \u0392-hexosaminidase activity in sporadic and genetic Parkinson disease","volume":"23","author":"Kim","year":"2016","journal-title":"Parkinsonism Relat Disord"},{"key":"2025072812075220000_5.2.e000535.56","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2008.05.032"},{"key":"2025072812075220000_5.2.e000535.57","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25748"},{"key":"2025072812075220000_5.2.e000535.58","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1001\/jamaneurol.2014.2950","article-title":"Evolution of Prodromal clinical markers of Parkinson disease in a GBA mutation-positive cohort","volume":"72","author":"Beavan","year":"2015","journal-title":"JAMA Neurol"},{"key":"2025072812075220000_5.2.e000535.59","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awaa181"},{"key":"2025072812075220000_5.2.e000535.60","doi-asserted-by":"publisher","DOI":"10.1111\/ene.15734"}],"container-title":["BMJ Neurology Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjno-2023-000535","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T19:08:01Z","timestamp":1753729681000},"score":1,"resource":{"primary":{"URL":"https:\/\/neurologyopen.bmj.com\/lookup\/doi\/10.1136\/bmjno-2023-000535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":60,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,11,24]]},"published-print":{"date-parts":[[2023,11]]}},"alternative-id":["10.1136\/bmjno-2023-000535"],"URL":"https:\/\/doi.org\/10.1136\/bmjno-2023-000535","relation":{},"ISSN":["2632-6140"],"issn-type":[{"value":"2632-6140","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11]]}}}